Bitdeer has sold its entire Bitcoin treasury of more than 1,127 BTC in February 2026 to raise liquidity for land purchases and infrastructure tied to AI and high‑performance computing. The miner began reducing its BTC balance from about 2,000 BTC at the start of 2026 and has now cleared its holdings while stressing that its self‑managed hash rate will keep growing. The move challenges the usual HODL approach among public Bitcoin miners as Bitdeer reallocates capital to higher‑margin AI and HPC data center operations.

On February 23, 2026, shares of Arcellx surged after Gilead Sciences agreed to buy the biotech company in a transaction valuing it at about $7.8 billion, including a $115 per share cash offer. The deal adds a potential $5 per share contingent value right tied to sales of Arcellx's CAR-T therapy anito-cel, while the stock price spiked to around $113.95 on heavy trading volume. The acquisition, expected to close in the second quarter of 2026, follows an existing partnership and could become accretive to Gilead's earnings after potential FDA approval.

On February 5 and 6, Bitcoin slipped below $61,000 before rebounding to $66,000–$68,000, while realized losses peaked near $1.24 billion per day and later eased to about $480 million. In early January 2026, USDT supply was about $187 billion and fell under $184 billion by mid‑February, with a 60‑day market‑cap change below ~$3 billion. Some analysts view these extremes and a Fear & Greed low near 5 as potential signs of market exhaustion.

According to the latest CoinShares data, crypto investment products posted $288 million in weekly outflows, marking a fifth consecutive week of redemptions and bringing total withdrawals to $4 billion. Bitcoin led the decline with $215 million in outflows, while Ethereum and Tron also saw institutional selling. In contrast, XRP and Solana attracted modest inflows of $3.5 million and $3.3 million respectively, with Chainlink adding $1.2 million, even as overall market sentiment remained bearish.

Stablecoin issuers are poised to become major buyers of short‑dated U.S. Treasuries, potentially adding $0.8T–$1T of demand by 2028. Market capitalization is projected to approach $2T, with reserve requirements under the July 2025 GENIUS Act concentrating assets in 0–3 month T‑bills. Emerging‑market adoption is expected to drive most of the expansion.

On Thursday, Austria's Financial Market Authority barred KuCoin EU from onboarding new clients or signing new products, citing shortcomings in AML, CTF and sanctions oversight. The action comes months after Austria granted the exchange a MiCA licence, and KuCoin says it has already paused onboarding and begun recruiting to restore key compliance roles.

On February 23, 2026, Novo Nordisk shares fell in premarket trading after the company said CagriSema did not demonstrate non-inferiority to Eli Lilly's tirzepatide in the REDEFINE 4 study. At 5:27 AM EST, NVO traded at $40.99, down $6.43 or 13.56% from the prior close.

Gemini co-founder Tyler Winklevoss has publicly stated he is optimistic at what he describes as peak crypto pessimism, even as filings and market data show mounting challenges for the exchange. SEC documents outline sharply higher operating expenses alongside modest revenue growth and a shrinking market value, while onchain data indicates Winklevoss Capital has cut its Bitcoin holdings by more than half over the past year. Gemini has also announced sizable layoffs, exited multiple regions and reshuffled senior leadership as it pivots toward new regulated products and services.